Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine

Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine

Abstract Background & aims Although metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with high multimorbidity and mortality, existing classification systems and risk prediction models largely ignore the heterogeneity of MASLD. Improved subtype definition could impro...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang Hong, Sheng-xing Liang, Ze-yang Li, Rui-ning Li, Hong-bo Zhu, Mingfei He, Hao Cui, Jing-zhe He, Yan Li, Jia-ren Wang, Xue-jing Zou, Wen-yuan Li, Lin Zeng, Li Liu, Lu-shan Xiao
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Translational Medicine
Subjects:
MASLD
Cluster
Clinical indicator
Complications
Genome-wide association study (GWAS)
Online Access:https://doi.org/10.1186/s12967-025-06670-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12967-025-06670-5

Similar Items